Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Vija Riekstina; V. Leimane; T. H. Holtz; J. Leimans; C. D. Wells

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Vija Riekstina^*
, V. Leimane
, T. H. Holtz
, J. Leimans
, C. D. Wells

^*Šī darba korespondējošais autors

State Agency for Tuberculosis and Lung Diseases
State Agency for TB and Lung Diseases of Latvia
Centers for Disease Control and Prevention

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

20 Atsauces (Scopus)

Kopsavilkums

International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

Oriģinālvaloda	Angļu
Lapas (no-līdz)	585-587
Lapu skaits	3
Žurnāls	International Journal of Tuberculosis and Lung Disease
Sējums	11
Izdevuma numurs	5
Publikācijas statuss	Publicēts - maijs 2007
Ārēji publicēts	Jā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

3. IAM — Laba Veselība un Labbūtība

Citi faili un saites

Saite uz publikāciju Scopus

Citēt šo

@article{9577c87ff74f488c83375ae69397378c,

title = "Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia",

abstract = "International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84\%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.",

keywords = "Cohort analysis, Multidrug-resistant tuberculosis, Treatment outcomes, Tuberculosis",

author = "Vija Riekstina and V. Leimane and Holtz, \{T. H.\} and J. Leimans and Wells, \{C. D.\}",

year = "2007",

month = may,

language = "English",

volume = "11",

pages = "585--587",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union Against Tuberculosis and Lung Disease ",

number = "5",

}

TY - JOUR

T1 - Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

AU - Riekstina, Vija

AU - Leimane, V.

AU - Holtz, T. H.

AU - Leimans, J.

AU - Wells, C. D.

PY - 2007/5

Y1 - 2007/5

N2 - International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

AB - International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

KW - Cohort analysis

KW - Multidrug-resistant tuberculosis

KW - Treatment outcomes

KW - Tuberculosis

UR - https://www.scopus.com/pages/publications/34248380501

M3 - Article

C2 - 17439686

AN - SCOPUS:34248380501

SN - 1027-3719

VL - 11

SP - 585

EP - 587

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 5

ER -

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Kopsavilkums

ANO IAM

Citi faili un saites

Nospiedums

Citēt šo